| ACT | Adoptive Cell Transfer |
| AML | Acute Myeloid Leukemia |
| ANRIL | Antisense Noncoding RNA in the INK4 Locus |
| APCs | Antigen-presenting cells |
| ARG1 | Arginase-1 |
| BANCR | BRAF-activated non-protein coding RNA |
| BET | Bromo- and Extra-Terminal domain |
| BRAF | V-Raf Murine Sarcoma Viral Oncogene Homolog B |
| BTLA | B- and T-lymphocyte attenuator |
| CAFs | Cancer Associated Fibroblasts |
| CAR T | Chimeric Antigen Receptor T cells |
| cGAS | Cyclic GMP-AMP synthase |
| CML | Chronic Myeloid Leukemia |
| CTLs | Cytotoxic T-lymphocytes |
| CTLA-4 | Cytotoxic T Lymphocyte-associated Antigen-4 |
| DITC | Dacarbazine |
| CBP/p300 | CREB binding protein/p300 |
| DNMT | DNA methyltransferase |
| ECM | Extracellular Matrix |
| EOMES | Eomesodermin |
| ERK1 | Extracellular signal-regulated kinase-1 |
| ERVs | Endogenous retroviruses |
| EZH2 | Enhanced of Zeste Homolog 2 |
| FOXP3 | Forkhead box P3 |
| HAT | Histone acetyltransferase |
| H3K27me3 | Trimethylation of Histone H3 at Lysine 27 |
| H3K4 | Histone H3 lysine 4 |
| H3K9 | Histone H3 lysine 9 |
| H3K36 | Histone H3 lysine 36 |
| H3K79 | Histone H4 lysine 79 |
| H3K9me3 | Trimethylation of Histone H3 at Lysine 9 |
| H3K27me3 | Trimethylation of Histone H3 at Lysine 27 |
| H4K20 | Histone H4 lysine 20 |
| HDAC | Histone deacetylase |
| HDM | Histone demethylase |
| HLA | Human leukocyte antigen |
| HMT | Histone methyltransferase |
| HOTAIR | HOX Transcript Antisense Intergenic RNA |
| ICAM-1 | Intercellular adhesion molecule 1 |
| ICIs | Immune Checkpoint Inhibitors |
| IFN-n | Interferon |
| IL-n | Interleukin |
| ISGs | Interferon Stimulated Genes |
| JAK/STAT | Janus kinase-signal transducer and activator of transcription |
| JARID1B | Jumonji AT-rich interactive domain 1B |
| JMJD2A | Jumonji domain-containing protein 2A |
| JNK | Jun N-terminal kinase |
| KDM6B | lysine (K)-specific demethylase 6B |
| LAG3+ | Lymphocyte-activation gene 3 |
| LDH | Lactate dehydrogenase |
| LMPn | Latent membrane protein |
| lncRNAs | Long non-coding RNAs |
| LSD1 | Lysine-specific demethylase 1 |
| MAGE | Melanoma Antigen Gene |
| MALAT1 | Metastasis-Associated Lung Adenocarcinoma Transcript 1 |
| MDS | Myelodysplastic syndrome |
| MDSCs | Myeloid-Derived Suppressor Cells |
| MELOE | Melanoma Overexpressed |
| MHC | Major histocompatibility complex |
| miRNAs/microRNAs | Small non-coding RNAs |
| MITF | Microphthalmia-associated transcription factor |
| MKT2D | Histone-lysine N-methyltransferase 2D |
| NK | Natural Killer |
| NSCLC | Non-Small Cell Lung Carcinoma |
| nLSD1p | Nuclear LSD1 phosphorylated at serine 111 |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| PFS | Progression-free survival |
| PI3K/Akt | phosphatidylinositol 3-kinase/Protein kinase B |
| PRC2 | Polycomb repressive complex 2 |
| PTM | Post-translational modification |
| PTPN1 | Protein Tyrosine Phosphatase Non-Receptor Type 1 |
| SAMMSON | Survival Associated Mitochondrial Melanoma Specific Oncogenic Non-coding RNA |
| SETDB1 | SET Domain Bifurcated Histone Lysine Methyltransferase 1 |
| SIRTs | Sirtuins |
| SPRY4-IT1 | SPRY4 Intronic Transcript 1 |
| STAT | Signal transducer and activator of transcription |
| STING | Stimulator of interferon genes |
| TAMs | Tumour-associated macrophages |
| TAPn | Transporter associated with antigen processing |
| T-BET | T-Box Transcription Factor 21 |
| TGF-β | Transforming growth factor beta |
| Th-1 | T-helper cell type-1 |
| TILS | Tumor-Infiltrating Lymphocytes |
| TIM3+ | T cell immunoglobulin and mucin-domain containing-3 |
| TME | Tumour microenvironment |
| TNF-α | Tumour necrosis factor alpha |
| TRAF6-TNF | Tumor Necrosis Factor Receptor Associated Factor 6-Tumor Necrosis Factor |
| Tregs | Regulatory T cells |
| TSA | Trichostatin |
| UCA1 | Urothelial Carcinoma Associated 1 |